Predictors of efficacy in patients (pts) with hormone receptor–positive/ human epidermal growth factor receptor 2–negative advanced breast cancer (HR+/HER2− ABC): Subgroup analyses of PALOMA-3. (October 2020) - Rugo, H.; Cristofanilli, M.; Loibl, S.; Harbeck, N.; Demichele, A.; Iwata, H.; Park, Y.H.; Brufsky, A.; Theall, K.Puyana; Huang, X.; McRoy, L.; Bananis, E.; et al.